Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AGNPF

Recent news which mentions AGNPF

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Tickers AGNPF ATAI CMND CMPS
Tags Cannabis AGNPF Kanna
From Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
Tickers AGNPF
Tags Psychedelics Research Market News Cannabis
From Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Tickers AGNPF ATAI AWKNF CMPS
Tags Small Cap DRUG Financing
From Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
Tickers AGNPF
Tags Psychedelics Benzinga Penny Stocks
From Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
Tickers AGNPF
Tags Markets AGNPF Market News
From Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
Tickers AGNPF CMND PSYGF
Tags Financing Psychedelic/Assisted Therapies Benzinga
From Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
Tickers AGNPF
Tags Benzinga Psychedelics DMT Entities
From Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Tickers AGNPF AWKNF BRAXF CMPS
Tags Cannabis AGNPF News
From Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
Tickers AGNPF
Tags AGNPF Benzinga Penny Stocks
From Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
Tickers AGNPF IPOS
Tags News Benzinga Psychedelics Capital Conference Penny Stocks
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Tickers AGNPF AWKNF CMND CYBN
Tags LMLLF ETFs Benzinga
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Tickers AGNPF AWKNF CYBN DMTTF
Tags IWINF NMLSF REUN
From Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
Tickers AGNPF TBI
Tags AGN Neuro Benzinga Psychedelics
From Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
Tickers AGNPF
Tags Guidance News Health Care
From Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
Tickers AGNPF DMT
Tags Cannabis Market News Markets
From Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
Tickers AGNPF
Tags Financing AGN Neuro Benzinga
From Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Tickers AGNPF ATAI FLHLF
Tags Psychedelic/Assisted Therapies FDA Legal
From Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Tickers AGNPF BMNDF CMND CMPS
Tags Elon Musk RVLWF Congressional Psychedelics Caucus
From Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
Tickers AGNPF
Tags Cannabis Market News AGNPF
From Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
Tickers AGNPF
Tags Penny Stocks News depression
From Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
Tickers AGNPF DMT
Tags Psychedelics Benzinga Legal
From Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
Tickers AGNPF
Tags Leiden University Medical Center Management Stroke
From Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
Tickers AGNPF
Tags AlphaNorth Asset Management Markets AGNPF
From Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
Tickers AGNPF
Tags Market News AGNPF General
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Tickers AGNPF ALID ATAI AWKNF
Tags Fabio Chianelli Cannabis BETRF
From Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Tickers AGNPF ALID ATAI AWKNF
Tags psychedelics MYNDF BRAXF
From Benzinga
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
Tickers AGNPF ALID ATAI FTRP
Tags Cannabis Dr/ Rick Strassman Market News
From Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
Tickers AGNPF ATOS GILD LLY
Tags Market News ATOS AGNPF
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.